Peptides are active substances used by the pharmaceutical industry.
They can be natural or synthetic and consist of a specific chaining of amino acids. This process, which is protected by numerous patents, allows a higher productivity level to be reached thanks to a major process simplification. Being very versatile, it can apply to all types of peptides and makes it possible to obtain extremely pure products. The plant has benefited from the support of the Brussels Region, and has been expanded several times, with a significant increase in production and quality control staff. Besides the manufacturing of a product used in cardiology, already marketed in the USA and in its launch phase in Europe, Peptisyntha is also developing the synthesis of new peptides for various other therapeutic fields, at the request of several customers.